A

Arbutus Biopharma

Vancouver, Canada Founded 2007 NASDAQ: ABUS

Nanomedicine Lipid Nanoparticles Drug Delivery Gene Therapy Delivery mRNA Delivery Nano-Bio

About

Develops lipid nanoparticle technology for hepatitis B and other infectious diseases

Company Details

Type: public
Employees: 100+
Funding: Public

Key Products

LNP Platform
HBV Therapeutics

Related Companies

Nanosphere (Luminex)

Northbrook, United States

NanoString Technologies

Seattle, United States

Nanobiotix

Paris, France

Arrowhead Research

Pasadena, United States